(Reuters) – Germany’s CureVac NV said on Tuesday it has started a mid-stage study testing its experimental coronavirus vaccine and plans to begin a much larger trial in the fourth quarter.
(Reporting by Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila)
